Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2010.603 | A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Trial of AMG 479 or Placebo in Combination with Gemcitabine as First-line Therapy for Metastatic Adenocarcinoma of the Pancreas | Dr Chan Stephen Lam |
| 2008.479 | A Randomized Phase I/II, Multi-Center, Open-Label Trial of PR104 and Sorafenib in Patients with Advanced Hepatocellular Carcinoma | Dr. Chan Stephen Lam |
| 2010.359 | A Phase II Study of Transarterial Chemoembolization and Axitinib for the Treatment of Unresectable Hepatocellular Carcinoma | Prof. CHAN Stephen Lam |
| 2013.338 | A phase II trial of PEG-BCT-100 as the second-line therapy following sorafenib in patients with advanced hepatocellular carcinoma | Dr. CHAN Stephen Lam |
| 2014.262 | A Phase 3, Multicenter, Open-label, Randomized Study of nab®-Paclitaxel Plus Gemcitabine versus Gemcitabine Alone as Adjuvant Therapy in Subjects with Surgically Resected Pancreatic Adenocarcinoma | Dr. CHAN Stephen Lam |
| 2013.474 | A Phase 3, Randomized, Double-blind, Controlled Study of Cabozantinib (XL184) vs Placebo in Subjects with Hepatocellular Carcinoma Who Have Received Prior Sorafenib | Dr. CHAN Stephen Lam |
| 2024.710 | DESTINY-Biliary Tract Cancer-01: A Phase 3 Study of Trastuzumab Deruxtecan (T-DXd) and Rilvegostomig versus Standard-of-Care Gemcitabine, Cisplatin, and Durvalumab for First Line Locally Advanced or Metastatic HER2-expressing Biliary Tract Cancer | Prof. CHAN Stephen Lam |
| 2024.379 | Phase 2 Study of Futibatinib 20 mg and 16 mg in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements | Prof. CHAN Stephen Lam |
| 2024.368 | A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an anti-TIM-3 Monoclonal Antibody, in Patients with Advanced Solid Tumors (AMBER) | Prof. CHAN Stephen Lam |
| 2024.724 | An Open-Label Phase 1/2 Study of WGI-0301 Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma as Second Line Therapy |
Prof. CHAN Stephen Lam 陳林 |
| 2024.646 | A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of TPST-1120 in Combination with Atezolizumab plus Bevacizumab Compared with Placebo plus Atezolizumab plus Bevacizumab in Patients with Unresectable or Metastatic Hepatocellular Carcinoma (HCC) Not Previously Treated with Systemic Therapy | Prof. CHAN Stephen Lam |
| 2025.184 | A Phase III, Randomised, Open-label, Sponsor-blinded, Multicentre Study of Rilvegostomig in Combination with Bevacizumab with or without Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma (ARTEMIDE-HCC01) | Prof. CHAN Stephen Lam |
| 2024.239 | A PHASE I STUDY OF ERY974 IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA | Prof. CHAN Stephen Lam |
| 2021.638 | A Multicountry, Multicentre, Noninterventional, Retrospective Study to Describe the Real-world Management Outcomes in Patients With Unresectable Hepatocellular Carcinoma |
Prof. CHAN Stephen Lam 陳林 |
| 2021.154 | A Phase 2, Randomized, Open-label Study of Relatlimab in Combination with Nivolumab in Participants with Advanced Hepatocellular Carcinoma who are Naive to IO Therapy but Progressed on Tyrosine Kinase Inhibitors (RELATIVITY-073) |
Dr. CHAN Stephen Lam 陳林 |
| 2022.533 | Artificial Intelligence for the Immune Profiling of Hepatocellular Carcinoma (AI-Immune-HCC) |
Prof. CHAN Stephen Lam 陳林教授 |
| 2011.388 | Prevalence of poorly controlled hypertension in Emergency Department patients in Hong Kong and the characteristics, disposition, referral or follow up patterns of these patients | Dr. Chan Stewart |
| 2011.094 | Current medical practice and relationships between medical treatment and cardiovascular indices measured by USCOM (Ultrasonic Cardiac Output Monotor) in patients with poorly controlled hypertension | Dr. Chan Stewart |
| 2011.370 | Noninvasive cardiac output monitoring to optimise therapy for patients with poorly controlled hypertension: a randomised controlled trial | Dr. Chan Stewart |
| 2023.133 | A prospective evaluation of early return-to-work (RTW) intervention group for patients with lower limbs injury in work rehabilitation program |
Ms. CHAN Sui Mei 陳瑞薇 |
| 2013.557 | A telephone follow-up study on work-related factors of return-to-work (RTW) among injured workers after musculoskeletal injury for 2 years | Ms Chan Sui Mei |
| 2008.127 | Experimental Study on the Psychophysiological and Neuropsychological Effects of Mindfulness-based Dan Tian Breathing Exercises in a Community Sample of Healthy and Depressed Individuals | Professor Chan Sui-yin |
| 2013.258 | Self-Control Interventions for Children with Autism Spectrum Disorders: Computerized Training vs Chinese Mind-Body Exercise | Prof. Chan Sui-yin, Agnes |
| 2017.477 | Frailty Intervention Trial for Healthy Ageing (FIT for Age): A randomized controlled trial assessing the effect of exercise program and individualized dietary recommendation on frailty | Prof. CHAN Suk Mei |
| 2024.062 | Increased Incidence of Paediatric Graves' Disease in Hong Kong Before and During COVID-19 | Dr Chan Suk Yan Suki |
| 2012.530 | A randomized crossover trial to compare the changes of postprandial oxidative stress after consumption of meals from different cultures in healthy Chinese adults | Prof Chan Suk-mei Ruth |
| 2013.379 | A pilot cross-sectional study examining the dietary intakes, nutrient intakes and nutritional status of Chinese women from early pregnancy to early postpartum in Hong Kong | Prof Chan Suk-mei, Ruth |
| 2009.257 | A propective observational study on pelvic floor disorders related to pregnancy | Dr Chan Symphorosa Shing Chee |
| 2013.332 | An observational follow up study on pelvic floor disorders related to 3 years after delivery | Dr. CHAN Symphorosa Shing Chee |
| 2023.603 | The attitude and success rate of women with pelvic organ prolapse on self-management of vaginal pessary: a multi-centered prospective study |
Dr. CHAN Symphorosa Shing Chee Shing Chee Symphorosa CHAN |
| 2022.617 | Effect of Virtual Reality and Music Therapy on Pain Relief in Outpatient Hysteroscopic Operations: A Randomized Controlled Trial |
Dr. CHAN Symphorosa Shing Chee 陳丞智 |
| 2016.081 | A randomised controlled trial on routine episiotomy versus restrictive episiotomy in Chinese nulliparous women |
Dr. CHAN Symphorosa Shing Chee 陳丞智 |
| 2017.005 | The prevalence of obstetric anal sphincter injury following vaginal delivery in Chinese primiparous women |
Dr. CHAN Symphorosa Shing Chee 陳丞智 |
| 2015.510 | Acupuncture for urinary incontinence in Chinese women: a randomized controlled trial |
Dr. CHAN Symphorosa Shing Chee 陳丞智 |
| 2015.125 | PROSPECTIVE OBSERVATIONAL STUDY OF OUTCOME OF TREATMENT TO WOMEN WITH PELVIC FLOOR DISORDERS |
Dr. CHAN Symphorosa Shing Chee 陳丞智 |
| 2015.085 | Symptom and Quality of life measurements in Chinese women with uterine fibroid – Validation study of The Uterine Fibroid Symptom and Quality of Life questionnaire |
Dr. CHAN Symphorosa Shing Chee 陳丞智 |
| 2013.477 | A follow up study on pelvic floor disorders related to post-instrumental deliveries | Dr. CHAN Symphorosa Shing Chee |
| 2015.203 | A pilot study to explore the diagnoses of urinary incontinence in women according to Traditional Chinese Medicine |
Dr. CHAN Symphorosa Shing chee 陳丞智 |
| 2024.176 | A Randomized Controlled Trial of High-Intensity Focused Ultrasound (HIFU) Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids | Dr. CHAN Symphorosa Shing Chee |
| 2018.387 | A randomized controlled trial of laser treatment in women with stress urinary incontinence |
Dr. CHAN Symphorosa Shing Chee 陳丞智 |
| 2013.594 | A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Multi-center Study to Evaluate the Long-Term Safety and Efficacy of Combination of Solifenacin Succinate with Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in Subjects with Overactive Bladder | Dr. CHAN Symphorosa Shing Chee |
| 2013.514 | A Randomized, Double-Blind, Parallel-Group, Placebo- and Active- Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder | Dr. CHAN Symphorosa Shing Chee |
| 2008.410 | A Phase II Study on the Therapeutics Effects of Acupuncture for Neurogenic Dysphagia | Ms Chan Sze Ling |
| 2011.592 | The change of knee isokinetic strength and kicking speed in response to the application of Kinesio taping on quadriceps in recreational soccer players. | Ms. Chan Sze Mei |
| 2008.044 | Association of Molecular Markers (MGMT and DNA-PK) with Chemotherapy Response in Southern Chinese Glioblastoma | Dr Chan Tat Ming |
| 2015.272 | Patterns of recurrence in glioblastoma treated with radiotherapy versus concomitant chemoradiotherapy |
Dr. CHAN Tat Ming 陳達明 |
| 2014.695 | Psychological adaptation into motherhood for pregnant women | Dr. CHAN Teresa Sau Fan |
| 2013.031 | The Retrospective Review on Gastroenteropancreatic Neuroendocrine Tumour Patients | Dr. Chan Ting Doris |
| 2020.529 | The effectiveness on single CPR quality of different height of ambulance stretcher at the scene. |
Mr. CHAN Ting Hin 陳庭軒 |
| 2020.694 | A retrospective study on the use of intraveous iron infusion in acute upper GI bleeding | Dr. CHAN Ting Ting |
Page 68 of 262.